See also this year's filing and all EDGAR filings for this company.
PDF Report 0001228627_2023_Ocuphire_Pharma_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001228627, Ocuphire Pharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 48,986,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 2,753,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,269,000 |
| 9 | ResearchAndDevelopmentExpense | 14,355,000 |
| 10 | remainder_Expenses | 324,000 |
| 11 | remainder_Revenues | 39,850,000 |
| 12 | remainder_NetIncome | -14,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 48,992,000 |
| 1 | Liabilities | 2,753,000 |
| 2 | Expenses | 21,948,000 |
| 3 | Revenues | 39,850,000 |
| 4 | StockholdersEquity | 46,239,000 |
| 5 | NetIncome | 17,888,000 |
| 6 | ComprehensiveNetIncome | 17,888,000 |
| 7 | BaseVar | 56,778,500 |
| 8 | EconomicCapitalRatio | 3.77 |
Edgar->Model Mapping
Feature Distribution
Change over Time
